These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19178759)

  • 41. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
    Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
    Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
    Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
    Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chitosan-based nanoparticles as delivery systems of therapeutic proteins.
    Fonte P; Andrade JC; Seabra V; Sarmento B
    Methods Mol Biol; 2012; 899():471-87. PubMed ID: 22735970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Polymeric drug carriers activated by ultrasounds energy].
    Kik K; Lwow F; Szmigiero L
    Polim Med; 2007; 37(3):59-65. PubMed ID: 18251205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.
    Hong K; Khwaja A; Liapi E; Torbenson MS; Georgiades CS; Geschwind JF
    Clin Cancer Res; 2006 Apr; 12(8):2563-7. PubMed ID: 16638866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted delivery of low molecular drugs using chitosan and its derivatives.
    Park JH; Saravanakumar G; Kim K; Kwon IC
    Adv Drug Deliv Rev; 2010 Jan; 62(1):28-41. PubMed ID: 19874862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and in vitro studies of biodegradable thiolated chitosan hydrogels for breast cancer therapy.
    Saboktakin MR; Tabatabaie RM; Maharramov A; Ramazanov MA
    Int J Biol Macromol; 2011 Jun; 48(5):747-52. PubMed ID: 21382403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanoparticles exposing neurotensin tumor-specific drivers.
    Falciani C; Brunetti J; Lelli B; Accardo A; Tesauro D; Morelli G; Bracci L
    J Pept Sci; 2013 Apr; 19(4):198-204. PubMed ID: 23436714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
    Chopra S; Mahdi S; Kaur J; Iqbal Z; Talegaonkar S; Ahmad FJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1021-32. PubMed ID: 16872548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy.
    Chang M; Yang CS; Huang DM
    ACS Nano; 2011 Aug; 5(8):6156-63. PubMed ID: 21732610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin.
    Ren Y; Wong SM; Lim LY
    Bioconjug Chem; 2007; 18(3):836-43. PubMed ID: 17407258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T lymphocytes as potential therapeutic drug carrier for cancer treatment.
    Steinfeld U; Pauli C; Kaltz N; Bergemann C; Lee HH
    Int J Pharm; 2006 Mar; 311(1-2):229-36. PubMed ID: 16460895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998).
    Csaba N; Alonso MJ
    J Control Release; 2014 Sep; 190():53-4. PubMed ID: 25356482
    [No Abstract]   [Full Text] [Related]  

  • 57. Borax mediated layer-by-layer self-assembly of neutral poly(vinyl alcohol) and chitosan.
    Manna U; Patil S
    J Phys Chem B; 2009 Jul; 113(27):9137-42. PubMed ID: 19530685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J; Chen XG; Peng WB; Liu CS
    Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applications of chitosan nanoparticles in drug delivery.
    Tajmir-Riahi HA; Nafisi Sh; Sanyakamdhorn S; Agudelo D; Chanphai P
    Methods Mol Biol; 2014; 1141():165-84. PubMed ID: 24567139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nucleic acid delivery with chitosan and its derivatives.
    Lai WF; Lin MC
    J Control Release; 2009 Mar; 134(3):158-68. PubMed ID: 19100795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.